IPO週報 | 醫渡科技孖展超購125倍，年度壓軸新股清科創業漲超40%
| 新股表現
2020年最後一週有5只新股上市，總體還是延續了近期新股火熱的情緒。除了二進宮的溫嶺工量刃具首日小幅破發，其餘4只都能盈利出場，CGII HLDGS和清科創業盤中漲幅都達到40%以上，概念獨特的瑞麗醫美盤中也有近30%的漲幅。
| 新股解盤
本週上市的新股都屬於中小市值公司，在表現上也符合今年的大數據規律，即從認購倍數和回撥角度看，“兩個極端”的新股表現較優。
uSMART在IPO年度覆盤中指出，從認購倍數看，人多的地方湊熱鬧，人少的地方可搏冷。
統計截止到2020年12月24日的數據，認購超過100倍的，首日收盤破發率18%，從盤中最高價來看，破發率只有4.5%。100倍以上的新股一般回撥50%，代表市場熱情極高，年度5只翻倍股落在這一區間。
認購1-15倍的，首日收盤破發率22%，從盤中最高價來看，破發率爲13%。15倍以內的新股一般不回撥，貨源集中，容易炒作，年度7只翻倍股都屬於這種情況。
瑞麗醫美、清科創業屬於前者，CGII HLDGS屬於後者，表現相對較好。而匯森家居和溫嶺工量刃具屬於中間熱度，但也沒有大幅破發，說明市場情緒較好。
| 正在招股
年底最後一天，新股扎堆招股再度上演，目前10只新股可供認購。
新股速遞 | 港股打新上演年度"壓軸大戰"，7只新股扎堆招股，醫療大數據"獨角獸"紛紛來襲
| 即將上市
下週僅有中邦環境、新紐科技2只新股上市。
| 最新遞表
| 新股消息
據報禹洲集團擬分拆禹佳生活服務上市，籌8億美元
據路透旗下《IFR》報道，禹洲集團(01628.HK)計劃分拆旗下物管服務公司禹佳生活服務上市，擬集資8億美元，預期明年上半年掛牌。中銀國際、海通國際爲聯席保薦人。
傳知乎擬美國或香港申請上市
據報道，內容服務平臺知乎正計劃在美國或香港申請上市，並已聘高盛、摩根士丹利和瑞信爲承銷行。
2019年8月12日，知乎完成了4.5億美元的F輪融資，該輪融資由快手領投、百度跟投，騰訊和今日資本原有投資方繼續跟投。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
